Pathway inhibitors for bridging to allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL)

被引:0
|
作者
Hahn, M. [1 ]
Dietrich, S. [1 ]
Hain, S-A [2 ]
Hegenbart, U. [1 ]
Rieger, M.
Scheuer, B.
Ho, A. D. [1 ]
Dreger, P. [1 ]
机构
[1] Heidelberg Univ, Med Klin 5, Heidelberg, Germany
[2] St Marien Krankenhaus, Med Klin 3, Siegen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V61
引用
收藏
页码:13 / 14
页数:2
相关论文
共 50 条
  • [41] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) FOR CHRONIC MYELOID LEUKEMIA (CML): THE TUNISIAN EXPERIENCE
    Torjemane, L.
    Abdejelil, N.
    Lakhal, A.
    Barhoumi, W.
    Elfatmi, R.
    Ladeb, S.
    Menif, S.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S144 - S144
  • [42] Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation
    Innocenti, Idanna
    Sora, Federica
    Autore, Francesco
    Chiusolo, Patrizia
    Giammarco, Sabrina
    Metafuni, Elisabetta
    Bacigalupo, Andrea
    Sica, Simona
    Laurenti, Luca
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (02) : 267 - 269
  • [43] Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
    Perutelli, Francesca
    Boccellato, Elia
    Catania, Gioacchino
    Frustaci, Anna Maria
    Innocenti, Idanna
    Moia, Riccardo
    Quaresmini, Giulia
    Gaidano, Gianluca
    Ladetto, Marco
    Laurenti, Luca
    Rambaldi, Alessandro
    Tedeschi, Alessandra
    Bruno, Benedetto
    Vitale, Candida
    Coscia, Marta
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S325 - S326
  • [44] Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
    Hill, Brian T.
    Ahn, Kwang Woo
    Hu, Zhen-Huan
    Aljurf, Mahmoud
    Beitinjaneh, Amer
    Cahn, Jean-Yves
    Cerny, Jan
    Kharfan-Dabaja, Mohamed A.
    Ganguly, Siddhartha
    Ghosh, Nilanjan
    Grunwald, Michael R.
    Inamoto, Yoshihiro
    Kindwall-Keller, Tamila
    Nishihori, Taiga
    Olsson, Richard F.
    Saad, Ayman
    Seftel, Matthew
    Seo, Sachiko
    Szer, Jeffrey
    Tallman, Martin
    Ustun, Celalettin
    Wiernik, Peter H.
    Maziarz, Richard T.
    Kalaycio, Matt
    Alyea, Edwin
    Popat, Uday
    Sobecks, Ronald
    Saber, Wael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : 581 - 586
  • [45] Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia
    Al-Sawaf, Othman
    Herling, Carmen Diana
    Holtick, Udo
    Scheid, Christoph
    Cramer, Paula
    Sasse, Stephanie
    von Tresckow, Bastian
    Tuchscherer, Armin
    Fischer, Kirsten
    Eichhorst, Barbara
    Hallek, Michael
    Frenzel, Lukas P.
    HAEMATOLOGICA, 2019, 104 (05) : E224 - E226
  • [46] REDUCED INTENSITY CONDITIONING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE CHRONIC LYMPHOCYTIC LEUKEMIA
    Kaur, H.
    Anthias, C.
    Baddeley, J.
    Byrne, J.
    Dasgupta, E.
    Ethell, M.
    Potter, M.
    Shaw, B.
    Russell, N.
    HAEMATOLOGICA, 2012, 97 : 403 - 403
  • [47] Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia (CLL) with 17p deletion: A retrospective EBMT analysis
    Schetelig, Johannes
    van Biezen, Anja
    Caballero, Dolores
    Rodrigo, Martino
    Remes, Kari
    Garcia-Marco, Jose A.
    Volin, Liisa
    Perez-Simon, Jose A.
    Schmitz, Norbert
    Schwerdtfeger, Rainer
    Ganser, Arnold
    Soligo, Davide
    Mohr, Brigitte
    Stilgenbauer, Stephan
    Brand, Ronald
    Ehninger, Gerhard
    de Witte, Theo
    Dreger, Peter
    BLOOD, 2007, 110 (11) : 22A - 23A
  • [48] Allogeneic stem cell transplantation in chronic lymphocytic leukemia: The con's
    Hallek, M
    Bergmann, M
    Wendtner, CM
    Fingerle-Rowson, G
    Schmitt, B
    ANNALS OF HEMATOLOGY, 2002, 81 : S48 - S50
  • [49] Allogeneic and autologous hematopoetic stem cell transplantation for chronic lymphocytic leukemia
    Kulkarni, S
    Powles, R
    Cunningham, D
    Sirohi, B
    Rudin, C
    Saso, R
    Treleaven, J
    Reiley, U
    Singhal, S
    Mehta, J
    Matutes, E
    Catovsky, D
    BONE MARROW TRANSPLANTATION, 2002, 29 : S165 - S165
  • [50] Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation
    Farina, L.
    Barretta, F.
    Scarfo, L.
    Bruno, B.
    Patriarca, F.
    Frustaci, A. M.
    Coscia, M.
    Salvetti, C.
    Quaresmini, G.
    Fanin, R.
    Onida, F.
    Magagnoli, M.
    Zallio, F.
    Vallisa, D.
    Reda, G.
    Ferrario, A.
    Corradini, P.
    Montillo, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : E256 - E262